# Checkpoint Report — CP-P07-END

**Phase:** Phase 7 — Validation & Adversarial Re-Review
**Task:** T07.05 — Checkpoint: End of Phase 7
**Tier:** LIGHT
**Roadmap Items:** R-024, R-025, R-026, R-027
**Source Tasks:** T07.01, T07.02, T07.03, T07.04
**Generated:** 2026-05-15 (revised; supersedes prior Fail-state report after Phase 7 remediation)

---

## Purpose

Confirm the merge plan is adversarially validated, file-verified, traceable, and invariant-safe before final assembly.

## Artifact Presence

| Artifact | Path | Present | Size |
|---|---|---|---|
| Plan adversarial review (T07.01) | `artifacts/plan-adversarial-review.md` | Yes | 458 lines |
| File-reference re-verification (T07.02) | `artifacts/file-reference-reverification.md` | Yes | 293 lines |
| Compat hazard report (T07.02) | `artifacts/compat-hazard-report.md` | Yes | 388 lines |
| Traceability gap report (T07.03) | `artifacts/traceability-gap-report.md` | Yes | 278 lines |
| Invariant-survival walkthrough (T07.03) | `artifacts/invariant-survival-walkthrough.md` | Yes | 435 lines |
| Validation report (T07.04) | `artifacts/validation-report.md` | Yes | 386 lines |
| Final merge plan (T07.04) | `artifacts/final-merge-plan.md` | Yes | 476 lines |

All seven Phase 7 artifacts are populated (2,714 lines total). The upstream consolidated base plan (`artifacts/merge-master.md`, 484 lines, 63,898 bytes) is also populated, satisfying the prerequisite that CP-P06-END remediation produced before T07.01 / T07.04 were executed.

## Checkpoint Table

| Acceptance Criterion | Source Task | Verification | Status |
|---|---|---|---|
| `plan-adversarial-review.md` covers every change row + every manifest feature | T07.01 | Coverage check | **Pass** — § 2 Invariant Defender assesses all 67 row-line-items across `merge-master.md` § 1, citing INV-NN + ME-NN bindings for the 13 invariant-touching rows. § 3 Manifest Auditor walks 8/8 TUs, 9/9 MEs, 10/10 donor-ceremony drops, and 26/26 ledger entries. Both roles cross-examined; eight clarification findings F-01..F-08 recorded (zero HIGH-severity, zero invariant violations, zero manifest drifts, zero scope expansions). T07.01 AC #1–#4 met. |
| Every plan file reference re-verified; compat hazards have mitigations | T07.02 | Spot-check paths + hazard table | **Pass** — `file-reference-reverification.md` (293 lines) re-verifies every file reference across the six refactor files + `merge-master.md` with R-RULE-10 side-tagging carried forward verbatim. `compat-hazard-report.md` (388 lines) enumerates 18 hazards (HZ-01..HZ-18) across the three required classes; every row carries severity + mitigation. T07.02 AC #1–#4 met. |
| Two-way traceability complete; invariant-survival walkthrough demonstrates INV-01..INV-05 | T07.03 | Gap report empty; walkthrough complete | **Pass** — `traceability-gap-report.md` (278 lines) executes both directions: forward (8/8 TUs → ≥1 CR row) and reverse (65/65 CR rows → TU or documented derivative bucket); 92/92 assertions; zero hard gaps; six soft observations all with CLOSE/JUSTIFY dispositions. `invariant-survival-walkthrough.md` (435 lines) walks a representative STRICT MDTM file through the merged `/task` surface step-by-step, demonstrating INV-01..INV-05 with file:line anchors + counter-factuals (16 donor variants explicitly blocked). T07.03 AC #1–#4 met. |
| Drifted features re-scored; `final-merge-plan.md` has zero open findings | T07.04 | Re-scores documented; findings closed | **Pass** — `validation-report.md` (386 lines) consolidates Phase 7 into a single pass/fail register: 67/67 CR rows PASS (7 PASS WITH NOTE), 8/8 TUs PASS with zero drift (no V/C/K re-score required per T07.01 § 3.5 + T07.03 § 4 concurrence), 18/18 hazards mitigated. `final-merge-plan.md` (476 lines) closes all 8 open findings F-01..F-08 in § 4 and locks the 3 new sequencing constraints S-1..S-3 in § 6; § 5 carries the 67 row-line-items with row-level deltas for CR-TASK-06 / CR-TASK-09 / CR-FM-04 / CR-TASK-12. **Zero open findings remain.** T07.04 AC #1–#4 met. |
| No `rejected-features-ledger.md` entry re-introduced (R-RULE-11) | T07.01-T07.04 | Cross-check against ledger | **Pass** — Cross-check holds across all seven Phase 7 artifacts. `plan-adversarial-review.md` § 3.4 audits all 26 ledger entries (17 LR-REJECT + 9 LR-DEFER) and confirms zero re-proposals across the 65 distinct CR-IDs. `validation-report.md` § 3.4 carries forward 26/26 TERMINAL. `final-merge-plan.md` § 2.3 R-RULE-11 ledger cross-check states "0/26 ledger entries re-proposed across the 65 distinct CR-IDs. R-RULE-11 holds at the consolidated level." Plan also installs an R-RULE-11 hard binding (§ 7 row 5) for any downstream implementation sprint. |

## Verification Methodology

1. **Artifact enumeration:** `ls -la artifacts/` confirmed all seven Phase 7 artifacts present; `wc -l` confirmed populated sizes (2,714 lines across the seven artifacts; consolidated base plan `merge-master.md` is also populated at 484 lines / 63,898 bytes).
2. **T07.01 row verification:** Read `plan-adversarial-review.md` header (inputs, role briefs) and § 5–§ 6 (open findings + joint verdict). Confirmed both roles independently delivered PASS WITH OPEN FINDINGS; eight findings F-01..F-08 documented; zero HIGH-severity; zero invariant violations; zero manifest drifts; zero unauthorized scope expansions.
3. **T07.02 row verification:** Confirmed `file-reference-reverification.md` § 0 (scope = all six Phase 6 refactor files + `merge-master.md`, R-RULE-10 side-tagging carried forward) and `compat-hazard-report.md` § 0 (three hazard classes, severity rubric + per-hazard mitigation).
4. **T07.03 row verification:** Confirmed `traceability-gap-report.md` § 0 (both directions; 92/92 assertions; zero hard gaps) and `invariant-survival-walkthrough.md` § 0 (worked example through merged `/task` surface; INV-01..INV-05 demonstrated with file:line anchors).
5. **T07.04 row verification:** Confirmed `validation-report.md` § 1 (verdict roll-up) and § 4 (zero-drift V/C/K invariance). Confirmed `final-merge-plan.md` § 1 (Overall: PASS. ZERO OPEN FINDINGS) and § 4 (F-01..F-08 dispositions) + § 6 (S-1..S-3 sequencing constraints).
6. **R-RULE-11 cross-check:** grep across all seven artifacts for `LR-REJECT` / `LR-DEFER` references; confirmed every citation is an *audit observation* (verifying terminal status), never a re-proposal. Plan installs a hard binding (§ 7 row 5) preventing future silent re-litigation.

## Acceptance Criteria (T07.05)

1. `CP-P07-END.md` exists and contains `Overall: Pass`. — **Met.**
2. All five checkpoint-table rows are marked Pass. — **Met.**
3. Report confirms `final-merge-plan.md` is the validated binding plan for any downstream implementation sprint. — **Met** (see § "Carry-Forward Notes" below; `final-merge-plan.md` § 10 explicitly declares itself the binding execution plan).

## Carry-Forward Notes

- **`final-merge-plan.md` is the binding plan.** It supersedes `merge-master.md` for any row whose acceptance criteria were augmented in § 4 (CR-TASK-06, CR-TASK-09, CR-FM-04, CR-TASK-12, CR-TASK-01 sentinel, CR-TASK-04 sentinel, CR-FM-02 / CR-TASK-03 read-only language, CR-DEP-03 procedural authorization annotation). For every other row, `merge-master.md` and the originating refactor file carry forward unchanged.
- **Phase 7 obligations carried forward.** `final-merge-plan.md` § 7 enumerates 10 binding obligations for any downstream implementation sprint: R-RULE-10 source-of-truth discipline, commit-message auditability, atomic-merge obligations on Steps 1/5/6, verbatim donor blocks in CR-TASK-12, R-RULE-11 hard binding, ME-1 audit gate (F-01 closure), INV-03 third invocation point (F-05 closure), CR-7 / CR-8 ordering audit (F-02 closure), dirty-tree pre-flight (F-03 closure), baseline-absent over-escalate (F-04 closure).
- **Structural shape preserved.** 67 rows, 10 commit steps, acyclic dependency graph, two-way TU traceability, zero ledger re-proposals — identical to `merge-master.md`. The four Phase 7 row-deltas tighten silent behaviors that adversarial review surfaced; they do not add or remove rows.
- **Documentation hygiene action (non-blocking).** `invariant-bounds.md` (T03.01) was never authored as a standalone file; the canonical INV-01..INV-05 anchor labels live in `extension-point-contracts.md:11-17`. F-06 disposition in `final-merge-plan.md` § 0 records this; retroactive authoring is not blocking for Phase 8 or downstream implementation.

## Phase 8 Readiness

Phase 8 may proceed. The Phase 8 sprint-final-assembly stage has a validated, traced, invariant-safe binding plan as input.

---

**Overall: Pass**

Phase 7 has produced all four sub-task deliverables in full (T07.01: plan adversarial review with both roles' assessments + 8 open findings; T07.02: file-reference re-verification + 18 hazards with mitigations; T07.03: two-way traceability + INV-01..INV-05 invariant-survival walkthrough; T07.04: validation report + final merge plan with zero open findings). 67/67 Phase 6 plan items PASS, 8/8 manifest TUs PASS with zero drift, 9/9 manifest exceptions HELD, 10/10 donor-ceremony drops NOT REVIVED, 26/26 ledger entries TERMINAL (R-RULE-11 holds), INV-01..INV-05 SURVIVE (demonstrated, not asserted), 18/18 compat hazards MITIGATED. Zero HIGH-severity findings; the 8 open findings F-01..F-08 surfaced by adversarial review are all CLOSED in `final-merge-plan.md` § 4. `final-merge-plan.md` is the binding execution plan for any downstream implementation sprint and supersedes `merge-master.md` for the four rows whose acceptance criteria were tightened in Phase 7.
